In vivo monitoring of tumor angiogenesis with MR imaging.
about
Tumor resistance to vascular disrupting agents: mechanisms, imaging, and solutionsIn Vivo Quantitative Microcomputed Tomographic Analysis of Vasculature and Organs in a Normal and Diseased Mouse ModelTumor vessel compression hinders perfusion of ultrasonographic contrast agents.Challenges for imaging angiogenesis.Blood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer.Intra-tumoural microvessel density in human solid tumours.Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.Validation of optimal DCE-MRI perfusion threshold to classify at-risk tumor imaging voxels in heterogeneous cervical cancer for outcome predictionUltra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer.Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model.MRI for assessing antivascular cancer treatments.PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging.Rapid simultaneous acquisition of T1 and T2 mapping images using multishot double spin-echo EPI and automated variations of TR and TE (ms-DSEPI-T12).Semi-quantitative contrast-enhanced MR analysis of indeterminate ovarian tumours: when to say malignancy?Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumoursPerfusion parameters of dynamic contrast-enhanced magnetic resonance imaging in patients with rectal cancer: correlation with microvascular density and vascular endothelial growth factor expressionThe role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: the Beth Israel Deaconess Medical Center (BIDMC) approachAssociations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept Study.Visualizing vascular permeability and lymphatic drainage using labeled serum albuminClinical imaging of tumor angiogenesis.SPIO-RGD nanoparticles as a molecular targeting probe for imaging tumor angiogenesis using synchrotron radiation.Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.Rectal cancer: 3D dynamic contrast-enhanced MRI; correlation with microvascular density and clinicopathological features.Oxygen distribution in murine tumors: characterization using oxygen-dependent quenching of phosphorescence.Non-invasive quantification of anti-angiogenic therapy by contrast-enhanced MRI in experimental pancreatic cancer.Correlative BOLD MR imaging of stages of synovitis in a rabbit model of antigen-induced arthritis.Accuracy of semiquantitative dynamic contrast-enhanced MRI for differentiating type II from type I endometrial carcinoma.Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer
P2860
Q26774355-67658E83-9EE1-468B-9177-2A6FC7177040Q27320156-C16EAC1E-2D8E-4685-B680-AEAEBF50C7BEQ30501504-A99D29C6-9B32-4329-96E3-1DD4A22E58A1Q34417138-6743AA81-AA3B-402F-B00E-57159AD91E44Q34534087-4EE89B4B-F9DA-4C80-BE35-7F3F88677B67Q34708258-794BFF04-97E5-40CE-A84C-4B5460495955Q34918635-D0DF328C-60CE-4B88-810B-C52E3A4CAAF3Q35142265-D50A9532-BCB5-4E74-B514-0AC52F83D109Q35185215-DEC9BB03-6625-463F-BB54-C750BB394446Q35216099-1583F57D-8E62-47AE-86C2-76F503B9F547Q35905005-976B56C1-DC26-437A-A779-29AE0AE12684Q36357752-E7A9FBE9-2F01-4D07-AC6D-24D09DD598F6Q36521082-2F0BCD4A-7FF3-48CF-8897-06D3B8EEA65DQ36550912-9CBBF1D5-69F2-416E-899F-3BABFB445A9BQ36671549-A6F4E70D-ED05-434B-BCDC-DAF35121FAC8Q37329986-73A02421-1BD7-41BF-926D-BD3D630243EAQ37337735-748ADB9D-0208-40A6-877D-3A95A7F57152Q37679045-142CCCED-DCDA-4EC0-93A7-A3A60E50CD27Q37761659-A741E83E-172C-4CCC-8019-61584C021F6AQ38059503-E9A16AEF-78C1-4A07-86DB-3F2C9D81CAD0Q39521937-4594598D-9B1D-4F8D-A87F-692BCBB8B088Q39543749-3ED07A1B-C8B6-4A7E-B07B-15EB032E0AD0Q44758231-A4326630-96DC-4273-8424-7F77DFC2632FQ45173457-344AC289-9EDD-4B54-81F1-83CD0F3A6E1FQ47920335-83D5AC48-B5A0-4018-A04C-C34D7BB5D23EQ51542151-9B40C1DF-A143-47A5-9333-E9AB3FCC206AQ54513993-E158A12F-D439-4FA0-BA2A-0B9BE34B480EQ57088963-D9C3F371-AD9D-4919-B011-4A560FD6CCA0
P2860
In vivo monitoring of tumor angiogenesis with MR imaging.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
In vivo monitoring of tumor angiogenesis with MR imaging.
@ast
In vivo monitoring of tumor angiogenesis with MR imaging.
@en
In vivo monitoring of tumor angiogenesis with MR imaging.
@nl
type
label
In vivo monitoring of tumor angiogenesis with MR imaging.
@ast
In vivo monitoring of tumor angiogenesis with MR imaging.
@en
In vivo monitoring of tumor angiogenesis with MR imaging.
@nl
prefLabel
In vivo monitoring of tumor angiogenesis with MR imaging.
@ast
In vivo monitoring of tumor angiogenesis with MR imaging.
@en
In vivo monitoring of tumor angiogenesis with MR imaging.
@nl
P2093
P1433
P1476
In vivo monitoring of tumor angiogenesis with MR imaging
@en
P2093
A R Padhani
J E Husband
K Turetschek
M T Keogan
R C Brasch
P304
P356
10.1016/S1076-6332(00)80630-3
P50
P577
2000-10-01T00:00:00Z